FDA grants accelerated approval to Genfit and Ipsen's liver disease drug

[cafead]

via The U.S. Food and Drug Administration has granted accelerated approval to French drugmakers Ipsen (IPN.PA) and Genfit's (GNFT.PA) to treat a chronic inflammatory liver disease, Ipsen said on Monday.

article source